Compass Pathways Teams Up With Mental Health Groups to Raise Awareness of Treatment-Resistant Depression

Key Points

• Compass Pathways announced the first-ever U.S. Treatment-Resistant Depression Awareness Day, with support from NAMI, Mental Health America and the Depression and Bipolar Support Alliance.
• The campaign aims to improve understanding, reduce stigma and encourage conversations about care when depression persists despite treatment.
• The announcement estimates that approximately 4 million Americans live with treatment-resistant depression.
• A new survey found that nearly 95% of respondents living with the condition described themselves as struggling or getting through each day.
• The initiative focuses on awareness and patient support. It does not include new clinical trial results or a regulatory update.

Compass Pathways (NASDAQ: CMPS) is working with leading mental health organizations to bring greater attention to treatment-resistant depression, or TRD, and its effects on patients, caregivers and families.

The company announced the first-ever U.S. TRD Awareness Day to help people recognize persistent treatment challenges, feel less isolated and discuss their care needs.

Campaign Highlights the Challenges of Depression That Persists Despite Treatment

The announcement describes a difficult journey for many patients: years of trying antidepressant treatments without meaningful relief, while depression continues to affect work, school, relationships and everyday life.

Compass estimates that approximately 4 million people in the U.S. live with TRD and that fewer than 5% are currently receiving a treatment specifically indicated for it. That figure does not mean the remaining patients receive no treatment; it refers specifically to treatments carrying a TRD indication.

The campaign is being amplified by the National Alliance on Mental Illness, Mental Health America and the Depression and Bipolar Support Alliance.

Survey Findings Show a Burden on Patients and Families

According to preliminary survey findings shared in the announcement, nearly 95% of respondents living with TRD described themselves as “functioning but struggling,” “surviving day-to-day” or “barely getting by.”

Caregivers also reported substantial challenges. Nearly two in three said TRD affected the whole family’s social, physical and/or mental health. More than half said caregiving had taken a major toll on their own mental health.

These findings highlight how the condition’s effects can extend beyond the person experiencing depression. However, the announcement does not provide the survey’s sample size or detailed methodology. Compass plans to release the full report in a future communication.